Literature DB >> 16306621

Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses.

Apurva Narechania1, Zigui Chen, Rob DeSalle, Robert D Burk.   

Abstract

The human papillomaviruses (HPVs) have long been thought to follow a monophyletic pattern of evolution with little if any evidence for recombination between genomes. On the basis of this model, both oncogenicity and tissue tropism appear to have evolved once. Still, no systematic statistical analyses have shown whether monophyly is the rule across all HPV open reading frames (ORFs). We conducted a taxonomic analysis of 59 mucosal/genital HPVs using whole-genome and sliding-window similarity measures; maximum-parsimony, neighbor-joining, and Bayesian phylogenetic analyses; and localized incongruence length difference (LILD) analyses. The algorithm for the LILD analyses localized incongruence by calculating the tree length differences between constrained and unconstrained nodes in a total-evidence tree across all HPV ORFs. The process allows statistical evaluation of every ORF/node pair in the total-evidence tree. The most significant incongruence was observed at the putative high-risk (i.e., cancer-associated) node, the common oncogenic ancestor for alpha HPV species 9 (e.g., HPV type 16 [HPV16]), 11, 7 (e.g., HPV18), 5, and 6. Although these groups share early-gene homology, including high degrees of similarity among E6 and E7, groups 9 and 11 diverge from groups 7, 5, and 6 with respect to L2 and L1. The HPV species groups primarily associated with cervical and anogenital cancers appear to follow two distinct evolutionary paths, one conferred by the early genes and another by the late genes. The incongruence in the genital HPV phylogeny could have occurred from an early recombination event, an ecological niche change, and/or asymmetric genome convergence driven by intense selection. These data indicate that the phylogeny of the oncogenic HPVs is complex and that their evolution may not be monophyletic across all genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306621      PMCID: PMC1316001          DOI: 10.1128/JVI.79.24.15503-15510.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Flexible sequence similarity searching with the FASTA3 program package.

Authors:  W R Pearson
Journal:  Methods Mol Biol       Date:  2000

2.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

3.  RDP: detection of recombination amongst aligned sequences.

Authors:  D Martin; E Rybicki
Journal:  Bioinformatics       Date:  2000-06       Impact factor: 6.937

4.  The Widespread Colonization Island of Actinobacillus actinomycetemcomitans.

Authors:  Paul J Planet; Scott C Kachlany; Daniel H Fine; Rob DeSalle; David H Figurski
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

5.  A new method to localize and test the significance of incongruence: detecting domain shuffling in the nuclear receptor superfamily.

Authors:  J W Thornton; R DeSalle
Journal:  Syst Biol       Date:  2000-06       Impact factor: 15.683

6.  The Bioperl toolkit: Perl modules for the life sciences.

Authors:  Jason E Stajich; David Block; Kris Boulez; Steven E Brenner; Stephen A Chervitz; Chris Dagdigian; Georg Fuellen; James G R Gilbert; Ian Korf; Hilmar Lapp; Heikki Lehväslaiho; Chad Matsalla; Chris J Mungall; Brian I Osborne; Matthew R Pocock; Peter Schattner; Martin Senger; Lincoln D Stein; Elia Stupka; Mark D Wilkinson; Ewan Birney
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

7.  Perils of paralogy: using HSP70 genes for inferring organismal phylogenies.

Authors:  Andrew P Martin; Theresa M Burg
Journal:  Syst Biol       Date:  2002-08       Impact factor: 15.683

8.  The carcinogenicity of human papillomavirus types reflects viral evolution.

Authors:  Mark Schiffman; Rolando Herrero; Rob Desalle; Allan Hildesheim; Sholom Wacholder; Ana Cecilia Rodriguez; Maria C Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Thomas C Wright; Diane Solomon; Zigui Chen; John Schussler; Philip E Castle; Robert D Burk
Journal:  Virology       Date:  2005-06-20       Impact factor: 3.616

9.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 10.  Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.

Authors:  Frauke Fehrmann; Laimonis A Laimins
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

View more
  34 in total

1.  Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.

Authors:  Samik Chakraborty; Kaushik Das; Shilpi Saha; Minakshi Mazumdar; Argha Manna; Sreeparna Chakraborty; Shravanti Mukherjee; Poulami Khan; Arghya Adhikary; Suchismita Mohanty; Samit Chattopadhyay; Subhash C Biswas; Gaurisankar Sa; Tanya Das
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Robert D Burk
Journal:  J Gen Virol       Date:  2007-11       Impact factor: 3.891

3.  Novel papillomavirus isolates from Erinaceus europaeus (Erinaceidae, Insectivora) and the Cervidae (Artiodactyla), Cervus timorensis and Pudu puda, and phylogenetic analysis of partial sequence data.

Authors:  Marc Gottschling; Gudrun Wibbelt; Ulrich Wittstatt; Eggert Stockfleth; Ingo Nindl
Journal:  Virus Genes       Date:  2008-01-22       Impact factor: 2.332

4.  Human papillomavirus genomics: past, present and future.

Authors:  Ariana Harari; Zigui Chen; Robert D Burk
Journal:  Curr Probl Dermatol       Date:  2014-03-13

5.  Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer.

Authors:  Zigui Chen; Luciana Bueno de Freitas; Robert D Burk
Journal:  Methods Mol Biol       Date:  2015

6.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

Authors:  Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

7.  Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity.

Authors:  Leiping Fu; Koenraad Van Doorslaer; Zigui Chen; Tutik Ristriani; Murielle Masson; Gilles Travé; Robert D Burk
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

8.  Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs).

Authors:  Zigui Chen; Koenraad van Doorslaer; Rob DeSalle; Charles E Wood; Jay R Kaplan; Janice D Wagner; Robert D Burk
Journal:  Virology       Date:  2009-08-28       Impact factor: 3.616

9.  A novel virus detected in papillomas and carcinomas of the endangered western barred bandicoot (Perameles bougainville) exhibits genomic features of both the Papillomaviridae and Polyomaviridae.

Authors:  Lucy Woolford; Annabel Rector; Marc Van Ranst; Andrea Ducki; Mark D Bennett; Philip K Nicholls; Kristin S Warren; Ralph A Swan; Graham E Wilcox; Amanda J O'Hara
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

10.  Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling.

Authors:  Seena D Shah; John Doorbar; Richard A Goldstein
Journal:  Mol Biol Evol       Date:  2010-01-21       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.